UnknownNot Applicable

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy

Italy400 participantsStarted 2022-03-23

Plain-language summary

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of sepsis scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of non M3 Acute Myeloid Leukemia according to WHO (World Health Organization) 2008 criteria * Age \>= 18 years and \<= 70 years * Patient had received intensive chemotherapy either as induction or consolidation regimen * Period of observation: January 2001 - December 2019 * Written informed consent Exclusion Criteria: * Diagnosis of Acute Promyelocytic Leukemia (M3 AML) * Age \< 18 or \>70 years * Patient had not received intensive chemotherapy

What they're measuring

Mortality risk

Timeframe: At baseline (fever onset), change at 24 hours from baseline, change at 48 hours from baseline

Trial details

NCT IDNCT05249894

SponsorA.O.U. Città della Salute e della Scienza

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-01

Contact for this trial

Chiara Frairia, MD

+390116335612 cfrairia@cittadellasalute.to.it

View on ClinicalTrials.gov More Acute Myeloid Leukemia trials